_id

690f3d6dccc777a4e85d1aa9

Ticker

CELZ

Name

Creative Medical Technology Holdings Inc

Exchange

NASDAQ

Address

211 East Osborn Road, Phoenix, AZ, United States, 85012

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.creativemedicaltechnology.com

Description

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, which is in IND-enabling phase, to treat infertility as a result of premature ovarian failure; iPSCelz, which is in pre-clinical stage, a platform to make cell type in the body; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Last Close

2.21

Volume

11783

Current Price

2.247

Change

1.6742081447963766

Last Updated

2025-11-29T11:19:08.558Z

Image

data:image/webp;base64,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

Ipo Date

2015-11-06T00:00:00.000Z

Market Cap

6941631

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.996

Sentiment Sources

1

Rating

4

Target Price

20

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

0

Gross Profit

0

Operating Expenses

1273034

Operating Income

-1273034

Interest Expense

-

Pretax Income

-1235934

Net Income

-1235934

Eps

-0.4789454267569633

Dividends Per Share

-

Shares Outstanding

2580532

Income Tax Expense

-

EBITDA

-1204875

Operating Margin

-

Total Other Income Expense Net

37100

Cash

5375511

Short Term Investments

-

Receivables

-

Inventories

994

Total Current Assets

5411541

Property Plant Equipment

-

Total Assets

5853003

Payables

247159

Short Term Debt

14194

Long Term Debt

-

Total Liabilities

261353

Equity

5591650

Depreciation

31059

Change In Working Capital

52557

Cash From Operations

-1168609

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

0

Net Change In Cash

-1168609

PE

-

PB

0.973759537882378

ROE

-22.10320746112507

ROA

-21.116237254619552

FCF

-1168609

Fcf Percent

-

Piotroski FScore

1

Health Score

42

Deep Value Investing Score

5.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

3.5

Quality Investing Score

2.5

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

0

Quarters > 0 > income Statement > gross Profit

0

Quarters > 0 > income Statement > operating Expenses

1273034

Quarters > 0 > income Statement > operating Income

-1273034

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-1235934

Quarters > 0 > income Statement > net Income

-1235934

Quarters > 0 > income Statement > eps

-0.4789454267569633

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

2580532

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-1204875

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

37100

Quarters > 0 > balance Sheet > cash

5375511

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

994

Quarters > 0 > balance Sheet > total Current Assets

5411541

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

5853003

Quarters > 0 > balance Sheet > payables

247159

Quarters > 0 > balance Sheet > short Term Debt

14194

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

261353

Quarters > 0 > balance Sheet > equity

5591650

Quarters > 0 > cash Flow > net Income

-1235934

Quarters > 0 > cash Flow > depreciation

31059

Quarters > 0 > cash Flow > change In Working Capital

52557

Quarters > 0 > cash Flow > cash From Operations

-1168609

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

0

Quarters > 0 > cash Flow > net Change In Cash

-1168609

Quarters > 0 > ratios > PE

-0.4789454267569633

Quarters > 0 > ratios > PB

0.973759537882378

Quarters > 0 > ratios > ROE

-22.10320746112507

Quarters > 0 > ratios > ROA

-21.116237254619552

Quarters > 0 > ratios > FCF

-1168609

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

42

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

30742

Quarters > 1 > income Statement > gross Profit

-30742

Quarters > 1 > income Statement > operating Expenses

1232778

Quarters > 1 > income Statement > operating Income

-1263520

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-1233303

Quarters > 1 > income Statement > net Income

-1233303

Quarters > 1 > income Statement > eps

-0.47792586954937977

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

2580532

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-1202561

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

30217

Quarters > 1 > balance Sheet > cash

6544120

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

994

Quarters > 1 > balance Sheet > total Current Assets

6632707

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

7105228

Quarters > 1 > balance Sheet > payables

263450

Quarters > 1 > balance Sheet > short Term Debt

14194

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

277644

Quarters > 1 > balance Sheet > equity

6827584

Quarters > 1 > cash Flow > net Income

-1233303

Quarters > 1 > cash Flow > depreciation

30742

Quarters > 1 > cash Flow > change In Working Capital

43814

Quarters > 1 > cash Flow > cash From Operations

-1158747

Quarters > 1 > cash Flow > capital Expenditures

3

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

-1158747

Quarters > 1 > ratios > PE

-0.47792586954937977

Quarters > 1 > ratios > PB

0.7974889096933849

Quarters > 1 > ratios > ROE

-18.06353462659705

Quarters > 1 > ratios > ROA

-17.357683666168068

Quarters > 1 > ratios > FCF

-1158750

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

42

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

3000

Quarters > 2 > income Statement > cost Of Revenue

1200

Quarters > 2 > income Statement > gross Profit

1800

Quarters > 2 > income Statement > operating Expenses

1662278

Quarters > 2 > income Statement > operating Income

-1660478

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-1638097

Quarters > 2 > income Statement > net Income

-1638097

Quarters > 2 > income Statement > eps

-0.8270147192834983

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

1980735

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-1629901

Quarters > 2 > income Statement > operating Margin

-55349.26666666666

Quarters > 2 > income Statement > total Other Income Expense Net

22381

Quarters > 2 > balance Sheet > cash

7702867

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

994

Quarters > 2 > balance Sheet > total Current Assets

7844011

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

8347274

Quarters > 2 > balance Sheet > payables

272193

Quarters > 2 > balance Sheet > short Term Debt

14194

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

286387

Quarters > 2 > balance Sheet > equity

8060887

Quarters > 2 > cash Flow > net Income

-1638097

Quarters > 2 > cash Flow > depreciation

30577

Quarters > 2 > cash Flow > change In Working Capital

12500

Quarters > 2 > cash Flow > cash From Operations

-1591535

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

3354000

Quarters > 2 > cash Flow > net Change In Cash

1762465

Quarters > 2 > ratios > PE

-0.8270147192834983

Quarters > 2 > ratios > PB

0.5184728243926505

Quarters > 2 > ratios > ROE

-20.321547740341728

Quarters > 2 > ratios > ROA

-19.624334842728295

Quarters > 2 > ratios > FCF

-1591535

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-530.5116666666667

Quarters > 2 > health Score

34

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

3000

Quarters > 3 > income Statement > cost Of Revenue

1200

Quarters > 3 > income Statement > gross Profit

1800

Quarters > 3 > income Statement > operating Expenses

1887534

Quarters > 3 > income Statement > operating Income

-1885734

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-1854074

Quarters > 3 > income Statement > net Income

-1854074

Quarters > 3 > income Statement > eps

-1.1227523896897416

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

1651365

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-1944698

Quarters > 3 > income Statement > operating Margin

-62857.799999999996

Quarters > 3 > income Statement > total Other Income Expense Net

31660

Quarters > 3 > balance Sheet > cash

5940402

Quarters > 3 > balance Sheet > short Term Investments

0

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

2194

Quarters > 3 > balance Sheet > total Current Assets

6135303

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

6669143

Quarters > 3 > balance Sheet > payables

273530

Quarters > 3 > balance Sheet > short Term Debt

14194

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

327644

Quarters > 3 > balance Sheet > equity

6341499

Quarters > 3 > cash Flow > net Income

-1854074

Quarters > 3 > cash Flow > depreciation

22639

Quarters > 3 > cash Flow > change In Working Capital

-126898

Quarters > 3 > cash Flow > cash From Operations

-1949536

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

1629500

Quarters > 3 > cash Flow > net Change In Cash

-320036

Quarters > 3 > ratios > PE

-1.1227523896897416

Quarters > 3 > ratios > PB

0.549456863432447

Quarters > 3 > ratios > ROE

-29.23715670380142

Quarters > 3 > ratios > ROA

-27.80078339900644

Quarters > 3 > ratios > FCF

-1949536

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-649.8453333333333

Quarters > 3 > health Score

33

Valuation > metrics > PE

-0.4789454267569633

Valuation > metrics > PB

0.973759537882378

Valuation > final Score

70

Valuation > verdict

2.6% Undervalued

Profitability > metrics > ROE

-22.10320746112507

Profitability > metrics > ROA

-22.838854958319637

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.04673987105773788

Risk > metrics > Interest Coverage

-40.98760423709714

Risk > final Score

-104

Risk > verdict

High

Liquidity > metrics > Current Ratio

20.70586907362839

Liquidity > metrics > Quick Ratio

20.702065788416434

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-104

Prev Risks > 1

-750

Prev Risks > 2

-23

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-12T15:06:59.895Z